Cellulitis Completed Phase 4 Trials for Daptomycin (DB00080)

Also known as: Cellulitis, unspecified

IndicationStatusPhase
DBCOND0014773 (Cellulitis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00295178Study Comparing CUBICINĀ® (Daptomycin for Injection) With Vancomycin in Cellulitis or ErysipelasTreatment
NCT01549613Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure InfectionsTreatment
NCT01626560The Effects of Daptomycin and Cytokines Production in Comparison With VancomycinBasic Science